{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:52:56Z","timestamp":1781279576405,"version":"3.54.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The present study aimed to investigate the clinical efficacy of endometrial ablation with high-intensity focused ultrasound (HIFU) for symptom relief in women with adenomyosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between July 2014 and July 2020, 167 patients with adenomyosis treated at the Zhongshan City People\u2019s Hospital were enrolled in this study. Patients were divided into two groups according to patient aspirations: the control group, including patients who only underwent ablation of adenomyosis lesions (group A) and the treatment group, including patients who underwent removal of adenomyosis lesions and endometrial ablation (group B).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The reduced dysmenorrhea scores (visual analog scale) and menstrual volume scores (pictorial blood assessment chart) were measured before and after treatment. The scores were obtained by subtracting the postoperative scores from the preoperative scores and were compared to determine whether the symptoms had alleviated. Compared with the menstrual volume of group A, that in group B showed significant improvements. The average relief rates of dysmenorrhea in the two groups also showed significant improvement. However, the scores in group B showed a more significant improvement than those in group A.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Therefore, our findings suggest that endometrial ablation using HIFU may be superior to conventional therapy with regard to alleviating the symptoms of increased menstruation in women with adenomyosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1332080","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:29:17Z","timestamp":1710995357000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["High-intensity focused ultrasound for endometrial ablation in adenomyosis: a clinical study"],"prefix":"10.3389","volume":"11","author":[{"given":"Siyun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.crad.2014.05.108","article-title":"MRI appearances of benign uterine disease","volume":"69","author":"Sudderuddin","year":"2014","journal-title":"Clin Radiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3126\/kumj.v10i1.6915","article-title":"Adenomyosis at hysterectomy: prevalence, patient characteristics, clinical profile and histopatholgical findings","volume":"10","author":"Shrestha","year":"2012","journal-title":"Kathmandu Univ Med J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.jmig.2021.06.002","article-title":"Comparison of high-intensity focused ultrasound and conventional surgery for patients with uterine myomas: a systematic review and meta-analysis","volume":"28","author":"Tsai","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/aogs.13159","article-title":"High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility","volume":"96","author":"Zhang","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"114.e1-7","DOI":"10.1016\/j.ajog.2012.06.027","article-title":"Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification","volume":"207","author":"Kishi","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/1471-0528.14740","article-title":"Application of dexmedetomidine-remifentanil in high-intensity ultrasound ablation of uterine fibroids: a randomised study","volume":"124","author":"Fu","year":"2017","journal-title":"BJOG"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1097\/MD.0000000000000650","article-title":"Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study","volume":"94","author":"Peng","year":"2015","journal-title":"Medicine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jvir.2014.08.027","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria\u2014a 10-year update","volume":"25","author":"Ahmed","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e2443","DOI":"10.1097\/MD.0000000000002443","article-title":"Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"S467","DOI":"10.1097\/01.RVI.0000094620.61428.9c","article-title":"Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata","volume":"14","author":"Goodwin","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijgo.2013.08.022","article-title":"Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound","volume":"124","author":"Zhang","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ultsonch.2015.05.024","article-title":"High-intensity focused ultrasound (HIFU) for adenomyosis: two-year follow-up results","volume":"27","author":"Shui","year":"2015","journal-title":"Ultrason Sonochem"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10815-022-02476-2","article-title":"Adenomyosis and infertility","volume":"39","author":"Moawad","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jmig.2019.07.029","article-title":"Is high-intensity focused ultrasound (HIFU) effective for the treatment of adenomyosis? A systematic review and meta-analysis","volume":"27","author":"Marques","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3109\/02656736.2016.1149232","article-title":"Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study","volume":"32","author":"Gong","year":"2016","journal-title":"Int J Hyperth"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.fertnstert.2010.10.020","article-title":"Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center","volume":"95","author":"Zhou","year":"2011","journal-title":"Fertil Steril"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/1471-0528.14736","article-title":"Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study","volume":"124","author":"Guo","year":"2017","journal-title":"BJOG"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"300060520976492","DOI":"10.1177\/0300060520976492","article-title":"Clinical effectiveness and potential long-term benefits of high-intensity focused ultrasound therapy for patients with adenomyosis","volume":"48","author":"Li","year":"2020","journal-title":"J Int Med Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/02656736.2019.1595179","article-title":"Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis","volume":"36","author":"Yang","year":"2019","journal-title":"Int J Hyperth"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.3390\/jcm12196130","article-title":"The present and the future of medical therapies for adenomyosis: a narrative review","volume":"12","author":"Moawad","year":"2023","journal-title":"J Clin Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1332080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:29:20Z","timestamp":1710995360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1332080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":21,"alternative-id":["10.3389\/fmed.2024.1332080"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1332080","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"article-number":"1332080"}}